| Revision as of 00:16, 18 September 2004 editNunh-huh (talk | contribs)30,738 edits temp save, back later...← Previous edit | Revision as of 01:05, 18 September 2004 edit undoNunh-huh (talk | contribs)30,738 editsNo edit summaryNext edit → | ||
| Line 17: | Line 17: | ||
| The diagnosis is generally entertained either on the basis of visual difficulties arising from the compression of the ] by the tumor, or on the basis of manifestations of excess hormone secretion: the specifics depend on the type of hormone. Tumors which cause visual difficulty are likety to be ''macroadenomas'' greater than 10 mm in diameter; tumors less than 10 mm are ''microadenomas''. | The diagnosis is generally entertained either on the basis of visual difficulties arising from the compression of the ] by the tumor, or on the basis of manifestations of excess hormone secretion: the specifics depend on the type of hormone. Tumors which cause visual difficulty are likety to be ''macroadenomas'' greater than 10 mm in diameter; tumors less than 10 mm are ''microadenomas''. | ||
| The most common secretory pituitary tumor is the prolactinoma, which can cause |
The most common secretory pituitary tumor is the prolactinoma, which can cause ], ], ], ], and ]. GH-secreting tumors cause ] (gigantism). Corticotrophic adenomas cause ]. TSH-secreting adenomas can, rarely, cause hyperthroidism. Tumors which secrete LH, FSH or TSH most often don't cause symptoms because of that hormone secretion. Some tumors secrete more than one hormone, the most common combination being GH and prolactin. | ||
| Prolactinomas are frequently diagnosed during pregnancy, when the ] ] increases the tumor's growth rate. | |||
| ⚫ | ==Treatment== | ||
| Headaches may be present. | |||
| The diagnosis is confirmed by testing hormone levels, and by radiographic imaging of the pituitary (for example, by ] or ]). | |||
| Treatment is usually surgery and patients respond well. A subtype, ] are seen commonly in women, and is frequently diagnised during pregnancy as the ] ] increases its growth. Efforts have been made to use a progesterone ] fot the treatment of prolactinomas, but so far have not proved successful. | |||
| ⚫ | ==Treatment== | ||
| Treatment options depend on the type of tumor and on its size. Prolactinomas are most often treated with ], a dopamine agonist, and followed by serial imaging to detect any increase in size. Treatment where the tumor is large can be radiological (proton beam irradiation) or surgical, and patients generally respond well. Efforts have been made to use a progesterone ] fot the treatment of prolactinomas, but so far have not proved successful. | |||
| {{stub}} | {{stub}} | ||
Revision as of 01:05, 18 September 2004
You must add a |reason= parameter to this Cleanup template – replace it with {{Cleanup|reason=<Fill reason here>}}, or remove the Cleanup template.
Pituitary adenomas are tumors that occur in the pituitary gland, and account for about 10% of intracranial neoplasms. They often remain undiagnosed, and small pituitary tumors are found in 6 to 24 percent of adults at autopsy.
Types
Pituitary tumors were, historically, classed as basophilic, acidophilic, or chromophobic on the basis of whether or not they took up the stains hematoxylin and eosin. This classification has fallen into disuse, in favor of a classification based on what type of hormone is secreted by the tumor (though tumors which do not secrete any active hormone ("non-functioning tumors" are still sometimes called "chromophobic").
At present, classification of pitutary tumors is based on immunohistochemical staining:
- corticotrophic adenomas secrete (ACTH) and (POMC)
- somatotrophic adenmoas secrete growth hormone (GH)
- thyrotrophic adenomas secrete thyroid stimulating hormone (TSH)
- gonadotrohic adenomas secrete luteinizing hormone (LH), follicle stimulating hormone (FSH) and their subunits
- lactrotrophic adenomas secrete prolactin
- null cell adenomas do not secrete hormones
Diagnosis
The diagnosis is generally entertained either on the basis of visual difficulties arising from the compression of the optic nerve by the tumor, or on the basis of manifestations of excess hormone secretion: the specifics depend on the type of hormone. Tumors which cause visual difficulty are likety to be macroadenomas greater than 10 mm in diameter; tumors less than 10 mm are microadenomas.
The most common secretory pituitary tumor is the prolactinoma, which can cause galactorrhea, hypogonadism, amenorrhea, infertility, and impotence. GH-secreting tumors cause acromegaly (gigantism). Corticotrophic adenomas cause Cushing's disease. TSH-secreting adenomas can, rarely, cause hyperthroidism. Tumors which secrete LH, FSH or TSH most often don't cause symptoms because of that hormone secretion. Some tumors secrete more than one hormone, the most common combination being GH and prolactin.
Prolactinomas are frequently diagnosed during pregnancy, when the hormone progesterone increases the tumor's growth rate.
Headaches may be present.
The diagnosis is confirmed by testing hormone levels, and by radiographic imaging of the pituitary (for example, by CT scan or MRI).
Treatment
Treatment options depend on the type of tumor and on its size. Prolactinomas are most often treated with bromocriptine, a dopamine agonist, and followed by serial imaging to detect any increase in size. Treatment where the tumor is large can be radiological (proton beam irradiation) or surgical, and patients generally respond well. Efforts have been made to use a progesterone antagonist fot the treatment of prolactinomas, but so far have not proved successful.
This article is a stub. You can help Misplaced Pages by expanding it. |